These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 27279371)

  • 1. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.
    Tsubouchi K; Araya J; Kuwano K
    Inflamm Regen; 2018; 38():18. PubMed ID: 30386443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis.
    Ito S; Araya J; Kurita Y; Kobayashi K; Takasaka N; Yoshida M; Hara H; Minagawa S; Wakui H; Fujii S; Kojima J; Shimizu K; Numata T; Kawaishi M; Odaka M; Morikawa T; Harada T; Nishimura SL; Kaneko Y; Nakayama K; Kuwano K
    Autophagy; 2015; 11(3):547-59. PubMed ID: 25714760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Tsubouchi K; Araya J; Yoshida M; Sakamoto T; Koumura T; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Hashimoto M; Wakui H; Numata T; Kaneko Y; Mori S; Asano H; Matsudaira H; Ohtsuka T; Nakayama K; Nakanishi Y; Imai H; Kuwano K
    J Immunol; 2019 Oct; 203(8):2076-2087. PubMed ID: 31534007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis.
    Larson-Casey JL; Deshane JS; Ryan AJ; Thannickal VJ; Carter AB
    Immunity; 2016 Mar; 44(3):582-596. PubMed ID: 26921108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway.
    Wang YC; Chen Q; Luo JM; Nie J; Meng QH; Shuai W; Xie H; Xia JM; Wang H
    Exp Mol Med; 2019 Mar; 51(3):1-11. PubMed ID: 30902967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
    Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
    J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
    Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
    J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
    Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X
    Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of 26S Proteasome Activity in Pulmonary Fibrosis.
    Semren N; Welk V; Korfei M; Keller IE; Fernandez IE; Adler H; Günther A; Eickelberg O; Meiners S
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1089-101. PubMed ID: 26207697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis.
    Chen X; Shi C; Cao H; Chen L; Hou J; Xiang Z; Hu K; Han X
    Cell Death Dis; 2018 May; 9(6):639. PubMed ID: 29844390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
    Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
    J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
    Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
    Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.